FDA advisers review SYD-101, low-dose atropine 0.01% for pediatric myopia, on Oct 30 after a 2025 complete response letter.
Feature|Articles|August 28, 2024
Ohio tackles pediatric eye health initiatives with Children’s Vision Strike Force
Author(s)Jordana Joy, Editor
The strike force involves more than a dozen medical and nonmedical professionals to help bridge the gap between failed vision screenings and follow-up examinations.
Advertisement
Advertisement
The state of Ohio, much like the rest of the country, is facing a pediatric eye care problem. Although several nonprofit organizations and government-funded programs and initiatives are working to ensure children’s eyes are examined, the fight continues to keep these examinations regular and consistent with a given patient’s needs in the state. However, these initiatives may see statewide regulation and growth thanks to a formative visit to southeastern Ohio made by Governor Mike DeWine.
Related to this article
Christina M. Danley, OD, FOVDR, explores the many nuances that require consideration when answering a common question asked by parents of children with myopia.
Kevin Chan, OD, MS, FAAO, FBCLA, IACMM, stated in his Rapid Fire lecture that high myopes shouldn't be counted out of orthokeratology treatment.
Magdalena Stec, OD, FAAO, and Noreen Shaikh, OD, MEd, FAAO, gave an overview of current evidence-based myopia control treatments in part of their AAOpt 2026 session.
FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites.
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host Diana Canto-Sims, OD.
Zachary Keaney, CPOA, discusses the lens care steps patients skip most often and why early diagnosis of lens-related keratitis is critical.
This week's top stories include breaking FDA approvals, insights on AI-assisted front desk management, and more.
Advertisement
Advertisement